Latest Orexo News & Updates

See the latest news and media coverage for Orexo. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Orexo

Pharmaceutical company developing innovative treatments

orexo.se
Headquarters
Fyrislund, Sweden
Founded year
1995
Company type
Public company
Number of employees
80–200

Last updated

Latest news about Orexo

In short: Orexo divested the U.S. rights for its lead product Zubsolv to Dexcel Pharma for $91 million and reported a widened Q1 2026 net loss of SEK 134m.

Company announcements

  • Orexo

    Orexo holds annual general meeting

    Resolves board re-elections, fees, auditor, no dividend, authorizations, and LTIP 2026.

  • Orexo

    Orexo publishes Q1 2026 interim report

    Revenues fall to SEK 5.0m; pipeline advances with Izipry NDA resubmission planned for Q3 2026 and OX640 pivotal studies in Q4. Bond redeemed early.

  • Orexo

    Orexo publishes Annual Report 2025

    It outlines strategic decisions, financial flexibility, and AmorphOX® advancements. The team receives thanks.

  • Orexo

    Orexo summons shareholders to AGM

    The meeting occurs on 7 May 2026 in Uppsala, covering board elections, remuneration guidelines, LTIP 2026, and share authorizations.

Unlock all announcements with a

Media coverage

  • Yahoo Finance

    Orexo AB (ORXOF) Q1 2026 Earnings Call Highlights: Strategic Divestment and R&D Investments ...

    Orexo AB (ORXOF) navigates a transitional quarter with a focus on restructuring, R&D advancements, and ongoing legal hurdles.

  • Dagens industri

    Orexo reports redder figures

    The specialist pharmaceutical company Orexo reports a net result of -134 million kronor (-15.9) for the first quarter of 2026. The result per...

  • The Globe and Mail

    Orexo updates share and voting structure after class C conversion

    Orexo AB has reported its updated share and vote structure as of the last trading day of March, confirming a total of 37,156,639 shares outstanding...

  • The Globe and Mail

    Orexo Calls 2026 AGM to Decide on Governance, Capital Measures and Incentive Plan

    Orexo AB has called its shareholders to an annual general meeting in Uppsala on 7 May 2026, outlining procedures for in-person attendance, proxy representation and...

Unlock all articles with a

Never miss news about Orexo

Track Orexo and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Orexo competitors & trending companies

Browse news for competitors to Orexo and other trending companies.